Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Compounding personalized medication: when is it appropriate?
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: JENSEN, Brenda (Compounding Consultants, LLC)
- Co-author(s): Brenda S Jensen: Compounding Consultants, LLC., Sioux Falls, United States
Lisa Diggs Ashworth: Pharmacy, Children's Health System of Texas, Dallas, United States
Eddy Hack: Compounding Consultants, LLC., Sioux Falls, United States
MethodsPharmacies in the United States must be licensed in their resident state and states where they ship or deliver medications. Each state has its own rules and regulations regarding compounding. Amid safety concerns, the Drug Quality and Security Act (DQSA) was passed in 2013 and mandates restrictions on compounding,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019